{"id":"https://openalex.org/W2592873500","doi":"https://doi.org/10.1182/blood.v126.23.5453.5453","title":"Pure Red Cell Aplasia after ABO-Mismatched Allogeneic Stem Cell Transplantation Treated with Therapeutic Plasma Exchange and Rituximab","display_name":"Pure Red Cell Aplasia after ABO-Mismatched Allogeneic Stem Cell Transplantation Treated with Therapeutic Plasma Exchange and Rituximab","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2592873500","doi":"https://doi.org/10.1182/blood.v126.23.5453.5453","mag":"2592873500"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.5453.5453","doi":"https://doi.org/10.1182/blood.v126.23.5453.5453","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.5453.5453","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031452560","display_name":"Rebecca Karp Leaf","orcid":"https://orcid.org/0000-0002-9978-8779","observed_orcids":["https://orcid.org/0000-0002-9978-8779"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Karp","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016770040","display_name":"Jon E. Arnason","orcid":"https://orcid.org/0000-0001-9038-7277","observed_orcids":["https://orcid.org/0000-0001-9038-7277"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jon E. Arnason","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054346063","display_name":"Jacalyn M. Rosenblatt","orcid":"https://orcid.org/0000-0001-5582-8161","observed_orcids":["https://orcid.org/0000-0001-5582-8161"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacalyn Rosenblatt","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052641327","display_name":"David Avigan","orcid":"https://orcid.org/0000-0003-4624-6017","observed_orcids":["https://orcid.org/0000-0003-4624-6017"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Avigan","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028590331","display_name":"Robin Joyce","orcid":"https://orcid.org/0000-0002-7251-8082","observed_orcids":["https://orcid.org/0000-0002-7251-8082"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robin Joyce","raw_affiliation_strings":["Hematology/Oncology, BIDMC, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, BIDMC, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071858483","display_name":"Myrna Rita Nahas","orcid":"https://orcid.org/0000-0002-6864-0931","observed_orcids":["https://orcid.org/0000-0002-6864-0931"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Myrna Rita Nahas","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057167861","display_name":"Erik J. Uhlmann","orcid":"https://orcid.org/0000-0003-1432-4754","observed_orcids":["https://orcid.org/0000-0003-1432-4754"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Erik Uhlmann","raw_affiliation_strings":["BETH ISRAEL DEACONESS MEDICAL CENTER, BOSTON, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BETH ISRAEL DEACONESS MEDICAL CENTER, BOSTON, MA","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112439914","display_name":"Ayad Hamdan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ayad Hamdan","raw_affiliation_strings":["Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5057167861","https://openalex.org/A5071858483","https://openalex.org/A5112439914"],"corresponding_institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.33428159,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"126","issue":"23","first_page":"5453","last_page":"5453"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11660","display_name":"Blood groups and transfusion","score":0.01640000008046627,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pure-red-cell-aplasia","display_name":"pure red cell aplasia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/therapeutic-plasma-exchange","display_name":"plasma exchange","score":0.8880000114440918},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.9210000038146973},{"id":"https://openalex.org/keywords/isohemagglutinins","display_name":"isoagglutinins","score":0.8230000138282776},{"id":"https://openalex.org/keywords/transfusion-independence","display_name":"transfusion independence","score":0.7979999780654907},{"id":"https://openalex.org/keywords/refractory-multiple-myeloma","display_name":"refractory multiple myeloma","score":0.8289999961853027},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9570000171661377},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9879999756813049},{"id":"https://openalex.org/keywords/conditioning-regimen","display_name":"conditioning regimen","score":0.32499998807907104}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8219431638717651},{"id":"https://openalex.org/C2777422296","wikidata":"https://www.wikidata.org/wiki/Q751631","display_name":"Pure red cell aplasia","level":3,"score":0.7899661064147949},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6953006982803345},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.6519538760185242},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.48805224895477295},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4809681475162506},{"id":"https://openalex.org/C2781440808","wikidata":"https://www.wikidata.org/wiki/Q846316","display_name":"Aplastic anemia","level":3,"score":0.43468862771987915},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.39442235231399536},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33412885665893555},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.2383328378200531},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.21661844849586487},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.18736273050308228}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.5453.5453","doi":"https://doi.org/10.1182/blood.v126.23.5453.5453","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.5453.5453","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4410828330","https://openalex.org/W1984738674","https://openalex.org/W2560312827","https://openalex.org/W2154967352","https://openalex.org/W4405049269","https://openalex.org/W2225440022","https://openalex.org/W2052003122","https://openalex.org/W2079593567","https://openalex.org/W2618996584","https://openalex.org/W4386282287"],"abstract_inverted_index":{"Abstract":[0],"Introduction":[1],"Pure":[2],"red":[3,55,198,287,647],"cell":[4,18,39,56,199,288,648],"aplasia":[5],"(PRCA)":[6],"is":[7,465],"a":[8,141],"severe":[9],"consequence":[10],"of":[11,24,54,70,86,131,154,197,226,235,253,280,295,304,309,326,338,342,355,367,374,391,399,415,429,436,442,444,447,453,503,520,523,544,566,575,597,656],"major":[12,167,400],"and":[13,52,125,137,147,158,162,171,178,242,264,267,306,340,363,431,451,455,471],"bi-directional":[14,172,402],"ABO-mismatched":[15,72,394],"allogeneic":[16],"stem":[17],"transplantation":[19,117],"(allo-SCT),":[20],"likely":[21],"the":[22,59,102,138,370,397,426,434,439],"result":[23],"persistent":[25,333],"isoagglutinin-producing":[26],"host":[27],"plasma":[28,38,96,642],"cells":[29],"that":[30],"have":[31],"escaped":[32],"pre-transplant":[33],"conditioning":[34,633],"or":[35,100,160,381,401,409],"graft":[36],"vs.":[37],"effect":[40],"(Aung":[41],"et.":[42],"al.":[43],"2013).":[44],"PRCA,":[45,227],"defined":[46,230],"as":[47,231],"anemia":[48],"with":[49,94,99,195,361,406,408,412],"reduced":[50,631],"reticuloytosis":[51],"absence":[53],"precursors":[57,237],"in":[58,112,168,173,208,221,250,273,359,369,383,396],"bone":[60,239],"marrow":[61,240],"at":[62],"60":[63],"days":[64,191,277,292,323,346,500,526,547,578,600],"after":[65,193,278,293,324,347,393,501,650],"transplantation,":[66,194],"complicates":[67],"about":[68],"10-20%":[69],"all":[71,176,184,209],"allo-SCTs;":[73],"however,":[74],"optimal":[75,440],"treatment":[76,435,472],"remains":[77],"unknown.":[78,461],"We":[79,387],"report":[80,388],"5":[81,579],"cases":[82,390],"from":[83],"our":[84],"institution":[85],"ABO":[87,164,403],"mismatched":[88],"allo-SCT":[89,395],"complicated":[90],"by":[91,201,315,571],"PRCA":[92,334,392,496,524,545,576,598],"treated":[93,405],"therapeutic":[95],"exchange":[97],"(PEX)":[98],"without":[101,410],"anti-CD20":[103],"monoclonal":[104],"antibody":[105],"rituximab.":[106],"Report":[107],"Patient":[108,469,474],"characteristics":[109,470],"are":[110],"shown":[111],"Table":[113,467],"1.":[114,468],"Indications":[115],"for":[116,150,433],"included":[118,206],"refractory":[119],"multiple":[120,604],"myeloma,":[121],"acute":[122,610],"myeloid":[123],"leukemia,":[124],"myelodysplastic":[126,607],"syndrome":[127],"(table":[128,213],"1);":[129],"four":[130,169,251,413],"five":[132,185,254,389,416],"patients":[133,170,216,255,261,417],"underwent":[134],"myeloablative":[135],"conditioning,":[136],"fifth":[139],"received":[140,218],"reduced-intensity":[142],"regimen":[143],"due":[144],"to":[145,223,270,318,365,419,646,658],"age":[146],"co-morbidities.":[148],"Prophylaxis":[149],"graft-versus-host":[151],"disease":[152,343,505],"consisted":[153],"cyclosporine":[155,157],"alone,":[156],"prednisone,":[159],"tacrolimus":[161],"prednisone.":[163],"mismatching":[165],"was":[166,357,376],"one":[174,283,350],"patient;":[175],"donors":[177],"recipients":[179],"were":[180],"Rh(D)":[181],"positive.":[182],"In":[183,259,282,349],"patients,":[186,210],"neutrophil":[187,639],"engraftment":[188,200,289,649],"occurred":[189,249,290],"between":[190],"11-15":[192],"failure":[196],"day":[202],"60.":[203],"Response":[204],"Intervention":[205],"PEX":[207,266,305,339,362,407,430,493,516,537,558,590],"performed":[211],"every-other-day":[212],"1).":[214],"Three":[215],"also":[217],"adjuvant":[219],"rituximab":[220,268,310,432],"addition":[222],"PEX.":[224,281,327,651],"Resolution":[225,522,543,574,596],"which":[228],"we":[229],"transfusion":[232,271,320],"independence,":[233],"presence":[234],"erythroid":[236],"on":[238,245],"biopsy,":[241],"\u00d2mixed":[243],"field\u00d3":[244],"blood":[246],"type":[247],"crossing,":[248],"out":[252,414],"(mean":[256],"95":[257],"days).":[258],"two":[260],"(patients":[262],"3":[263,527],"5)":[265],"led":[269,364],"independence":[272,321],"less":[274],"than":[275],"30":[276],"initiation":[279,294,325],"patient":[284,298,329,351,457],"(patient":[285,299,330,352],"2),":[286,353],"87":[291,525],"PEX;":[296],"another":[297],"4)":[300],"required":[301],"10":[302,336,494,517,538,559],"sessions":[303,337,443,495,518,539,560,592],"2":[307,506,541],"cycles":[308,565],"(4":[311],"weekly":[312,568],"doses":[313,542,563,569,595],"separated":[314,570],"6":[316,572],"months)":[317,573],"achieve":[319],"253":[322,577],"One":[328],"1)":[331],"had":[332],"despite":[335],"died":[341],"relapse":[344],"398":[345,499],"transplantation.":[348],"tapering":[354],"immunosuppression":[356,375,521],"attempted":[358],"conjunction":[360],"resolution":[366],"PRCA;":[368],"other":[371],"four,":[372],"withdrawal":[373],"either":[377],"not":[378],"clinically":[379],"indicated":[380],"unsuccessful":[382],"resolving":[384],"PRCA.":[385,437],"Conclusion":[386],"setting":[398],"incompatibility":[404],"rituximab,":[411,454],"responding":[418],"this":[420,448],"intervention.":[421],"This":[422],"case":[423],"series":[424],"demonstrates":[425],"potential":[427],"efficacy":[428],"However,":[438],"number":[441],"PEX,":[445],"timing":[446],"intervention,":[449],"dosing":[450],"schedule":[452],"appropriate":[456],"selection":[458],"still":[459],"remain":[460],"A":[462],"prospective":[463],"study":[464],"planned.":[466],"outcomes":[473],"Age":[475],"Disease":[476],"Graft":[477],"Conditioning":[478],"Recipient/Donor":[479],"ANC>500":[480],"Treatment":[481],"Outcome/TTE":[482],"1":[483],"48M":[484],"IgG":[485],"MM":[486],"PB":[487,510,531,552,583],"MURD":[488,511],"MyeloablativeBu/Cy":[489,554],"O+/A+":[490,534,587],"F":[491,556],"D+15":[492,589],"unresolved":[497],"Died":[498],"transplant":[502],"recurrent":[504],"56":[507],"M":[508,514,529,535,550,581,588],"MDS":[509,582],"MyeloablativeFlu/Bu/ATG":[512],"O+/B+":[513],"D+11":[515,557],"Withdrawal":[519],"58":[528],"AML":[530,551],"MRD":[532,553,584],"MyeloablativeFlu/Bu":[533],"D+13":[536],"Rituximab":[540,561,593],"13":[546],"4":[548,567,594],"49":[549],"B+/A+":[555],"8":[562],"(2":[564],"70":[580],"RIC":[585],"Flu/Bu":[586],"7":[591],"15":[599],"M:":[601],"male;":[602],"MM:":[603],"myeloma;":[605],"MDS:":[606],"syndrome;":[608],"AML:":[609],"myelogenous":[611],"leukemia":[612],"PB:":[613],"peripheral":[614],"blood;":[615],"MRD:":[616],"matched":[617,621],"related":[618],"donor;":[619,623],"MURD:":[620],"unrelated":[622],"Bu:":[624],"busulfan;":[625],"Cy:":[626],"cyclophosphamide;":[627],"Flu:":[628],"fludarabine;":[629],"RIC:":[630],"intensity":[632],"regimen;":[634],"F:":[635],"female;":[636],"ANC:":[637],"absolute":[638],"count;":[640],"PEX:":[641],"exchange;":[643],"TTE:":[644],"time":[645],"Disclosures":[652],"No":[653],"relevant":[654],"conflicts":[655],"interest":[657],"declare.":[659]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2017-03-16T00:00:00"}